α-Catenin expression has prognostic value in local and locally advanced prostate cancer

[1]  T. Visakorpi,et al.  Molecular genetics of prostate cancer. , 2003, Annals of medicine.

[2]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[3]  J. Schalken,et al.  Decreased expression of α‐catenin is associated with poor prognosis of patients with localized renal cell carcinoma , 1997 .

[4]  S. M. Phillips,et al.  Genetic alterations in incidentally diagnosed, transitional zone prostate cancer: a seven year follow-up. , 1997, The Journal of urology.

[5]  W. Isaacs,et al.  Relation between aberrant α‐catenin expression and loss of E‐cadherin function in prostate cancer , 1997, International journal of cancer.

[6]  A. Nagafuchi,et al.  Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. , 1997, Cancer research.

[7]  J. Arends,et al.  Patterns of α‐ and β‐catenin and E‐cadherin expression in colorectal adenomas and carcinomas , 1997 .

[8]  W. Isaacs,et al.  The cadherin cell-cell adhesion pathway in prostate cancer progression. , 1997, British journal of urology.

[9]  O. Cussenot,et al.  Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. , 1997, European journal of cancer.

[10]  J. Schalken,et al.  Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. , 1996, Cancer research.

[11]  J. S. Morrow,et al.  Reduced alpha-catenin and E-cadherin expression in breast cancer. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[12]  P. Lipponen,et al.  Mitotic activity and prognosis in prostatic adenocarcinoma , 1995, The Prostate.

[13]  P. Lipponen,et al.  Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy. , 1994, British Journal of Cancer.

[14]  W. Isaacs,et al.  Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. , 1994, Cancer research.

[15]  P. McCrea,et al.  Catenins as mediators of the cytoplasmic functions of cadherins , 1993, Journal of Cell Science.

[16]  W. Isaacs,et al.  Reduction of E-Cadherin Levels and Deletion of the α-Catenin Gene in Human Prostate Cancer Cells , 1993 .

[17]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[18]  W. Birchmeier,et al.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.

[19]  W. Birchmeier,et al.  Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion , 1989, The Journal of cell biology.

[20]  W. Birchmeier,et al.  Expression of E-cadherin and catenins in invasive mammary carcinomas. , 1997, Anticancer research.

[21]  M. Mareel,et al.  Regulation of the invasion suppressor function of the cadherin/catenin complex. , 1996, Pathology, research and practice.

[22]  W. Isaacs,et al.  Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. , 1993, Cancer research.